Deciphering the role of mitochondrial cytochrome C oxidase subunit 4 in cardiac health and disease
- 26 February 2026
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 391, 124295
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Heart Failure Outcomes and Empagliflozin Effects in Patients with Heart Failure and Reduced Ejection Fraction in Sinus Rhythm or Atrial Fibrillation: Data from EMPEROR-ReducedEuropean Journal of Heart Failure, 2025
- Trimetazidine in Cardiovascular Disease and Beyond: A Comprehensive ReviewAmerican Journal of Cardiovascular Drugs, 2025
- Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant-Level Pooled Analysis of the CANVAS and CREDENCE TrialsEuropean Journal of Heart Failure, 2025
- Deciphering the role of mtH2O2 in hepatic ischemia-reperfusion injury mechanisms with low-background super-resolution fluorogenic probeScience China Chemistry, 2024
- Methylene blue reduces monoamine oxidase expression and oxidative stress in human cardiovascular adipose tissueMolecular and Cellular Biochemistry, 2024
- Genistein alleviates doxorubicin‐induced cardiomyocyte autophagy and apoptosis via ERK/STAT3/c‐Myc signaling pathway in rat modelPhytotherapy Research, 2024
- The Ratio of Cytochrome C Oxidase Subunit 4 Isoform 4I1 and 4I2 mRNA is Changed in Permanent Atrial FibrillationESC Heart Failure, 2023
- Autophagy-related 7 protein-dependent autophagy mediates resveratrol-caused upregulation of mitochondrial biogenesis and steroidogenesis in aged Leydig cellMolecular Biology Reports, 2023
- Prevalence of heart disease in patients with mitochondrial abnormalities on skeletal muscle biopsyAnnals of Clinical and Translational Neurology, 2021
- Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction: GALACTIC-HF Baseline Characteristics and Comparison with Contemporary Clinical TrialsEuropean Journal of Heart Failure, 2020